Drug intelligence / Profile preview

Hypericum Syxyl

Development stage: Unknown
Lead developer: Homeosyn Italia
Administration: Oral

Overview

Hypericum Syxyl is a homeopathic preparation and nutraceutical developed and marketed by Homeosyn Italia. It is formulated as oral drops containing a 1000K potency of *Hypericum perforatum* (St. John's Wort). In homeopathic practice, Hypericum is traditionally indicated for conditions affecting the peripheral and central nervous systems, such as neuralgia, nerve trauma, and mild depressive states, as well as for promoting the healing of lacerated wounds. As a homeopathic product, it is available through pharmacies and online retailers in Italy and does not follow a standard pharmaceutical clinical development pipeline.

Brand names: Hypericum SyxylHypericum Syxyl 1000K
Other names: Hypericum Syxyl 1000K GTTHypericum Syxyl 1000K gocce

Beyond the preview

Go deeper on Hypericum Syxyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypericum Syxyl.

Explore the full profile